Position in QGEN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$243,323
New position
Shares Held
6,077
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Polymer Capital Management (US) LLC holds $3,954,110 across 8 Diagnostics & Research names. QGEN ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
11,101 | $1,265,291 | |
| 2 | DHR |
Danaher Corp /De/
|
4,072 | $772,051 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
361 | $455,293 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
767 | $377,003 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
740 | $355,340 | |
| 6 | WAT |
Waters Corp /De/
|
939 | $279,634 | |
| 7 | QGEN |
Qiagen N.V.
This page
|
6,077 | $243,323 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
12,967 | $206,175 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243,323 | 6,077 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||